Left-sided cardiac valvulitis in tristetraprolin-deficient mice: The role of tumor necrosis factor α

American Journal of Pathology

Volumn 176, Issue 3, 2010, Pages 1484-1493

  Ghosh, Sanjukta ^a   Hoenerhoff, Mark J ^a   Clayton, Natasha ^a   Myers, Page ^a   Stumpo, Deborah J ^a   Maronpot, Robert R ^a   Blackshear, Perry J ^a,b  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRISTETRAPROLIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA VALVE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; HEART VALVULITIS; HISTOPATHOLOGY; MALE; MITRAL VALVE; MOUSE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY VALVE; TRICUSPID VALVE; VALVULAR HEART DISEASE;

EID: 77749304052     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.090498     Document Type: Article

References (55)

1. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M: Burden of valvular heart diseases: a population-based study. Lancet 2006, 368:1005-1011
2. Rajamannan NM, Nealis TB, Subramaniam M, Pandya S, Stock SR, Ignatiev CI, Sebo TJ, Rosengart TK, Edwards WD, McCarthy PM, Bonow RO, Spelsberg TC: Calcified rheumatic valve neoangiogenesis is associated with vascular endothelial growth factor expression and osteoblast-like bone formation. Circulation 2005, 111:3296-3301
3. Dellegrottaglie S, Sanz J, Rajagopalan S: Molecular determinants of vascular calcification: a bench to bedside view. Curr Mol Med 2006, 6:515-524
4. Wallby L, Steffensen T, Broqvist M: Role of inflammation in nonrheumatic, regurgitant heart valve disease. A comparative, descriptive study regarding apolipoproteins and inflammatory cells in nonrheumatic heart valve disease. Cardiovasc Pathol 2007, 16:171-178
5. Helske S, Oksjoki R, Lindstedt KA, Lommi J, Turto H, Werkkala K, Kupari M, Kovanen PT: Complement system is activated in stenotic aortic valves, Atherosclerosis 2008, 196:190-200
6. Rajamannan NM, Subramaniam M, Springett M, Sebo TC, Niekrasz M, McConnell JP, Singh RJ, Stone NJ, Bonow RO, Spelsberg TC: Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation 2002, 105:2660-2665
7. Poggianti E, Venneri L, Chubuchny V, Jambrik Z, Baroncini LA, Picano E: Aortic valve sclerosis is associated with systemic endothelial dysfunction. J Am Coll Cardiol 2003, 41:136-141
8. Chandra HR, Goldstein JA, Choudhary N, O'Neill CS, George PB, Gangasani SR, Cronin L, Marcovitz PA, Hauser AM, O'Neill WW: Adverse outcome in aortic sclerosis is associated with coronary artery disease and inflammation. J Am Coll Cardiol 2004, 43:169-175
9. Agmon Y, Khandheria BK, Jamil Tajik A, Seward JB, Sicks JD, Fought AJ, O'Fallon WM, Smith TF, Wiebers DO, Meissner I: Inflammation, infection, and aortic valve sclerosis; Insights from the Olmsted County (Minnesota) population. Atherosclerosis 2004, 174:337-342
10. Fox CS, Guo CY, Larson MG, Vasan RS, Parise H, O'Donnell CJ, D'Agostino RB, Sr., Keaney JF Jr, Benjamin EJ: Relations of inflammation and novel risk factors to valvular calcification. Am J Cardiol 2006, 97:1502-1505
11. Freeman RV, Otto CM: Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation 2005, 111:3316-3326
12. Taylor GA, Carballo E, Lee DM, Lai WS, Thompson MJ, Patel DD, Schenkman DI, Gilkeson GS, Broxmeyer HE, Haynes BF, Blackshear PJ: A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 1996, 4:445-454
13. Lai WS, Carballo E, Strum JR, Kennington EA, Phillips RS, Blackshear PJ: Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA. Mol Cell Biol 1999, 19:4311-4323
14. Carballo E, Blackshear PJ: Roles of tumor necrosis factor-alpha receptor subtypes in the pathogenesis of the tristetraprolin-deficiency syndrome. Blood 2001, 98:2389-2395
15. Carballo E, Lai WS, Blackshear PJ: Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 1998, 281:1001-1005
16. Carballo E, Lai WS, Blackshear PJ: Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deadenylation and stability. Blood 2000, 95:1891-1899
17. Chen YL, Huang YL, Lin NY, Chen HC, Chiu WC, Chang CJ: Differential regulation of ARE-mediated TNFalpha and IL-1beta mRNA stability by lipopolysaccharide in RAW264.7 cells. Biochem Biophys Res Commun 2006, 346:160-168
18. Stoecklin G, Tenenbaum SA, Mayo T, Chittur SV, George AD, Baroni TE, Blackshear PJ, Anderson P: Genome-wide analysis identifies interleukin-10 mRNA as target of tristetraprolin. J Biol Chem 2008, 283:11689-11699
19. Lai WS, Parker JS, Grissom SF, Stumpo DJ, Blackshear PJ: Novel mRNA targets for tristetraprolin (TTP) identified by global analysis of stabilized transcripts in TTP-deficient fibroblasts. Mol Cell Biol 2006, 26:9196-9208
20. Datta S, Biswas R, Novotny M, Pavicic PG Jr, Herjan T, Mandal P, Hamilton TA: Tristetraprolin regulates CXCL1 (KC) mRNA stability. J Immunol 2008, 180:2545-2552
21. Saber AT, Jacobsen NR, Bornholdt J, Kjaer SL, Dybdahl M, Risom L, Loft S, Vogel U, Wallin H: Cytokine expression in mice exposed to diesel exhaust particles by inhalation. Role of tumor necrosis factor. Part Fibre Toxicol 2006, 3:4
22. Hirsch S, Gordon S: Polymorphic expression of a neutrophil differentiation antigen revealed by monoclonal antibody 7/4. Immunogenetics 1983, 18:229-239
23. Rabinowitz SS, Gordon S: Macrosialin, a macrophage-restricted membrane sialoprotein differentially glycosylated in response to inflammatory stimuli. J Exp Med 1991, 174:827-836
24. Hughes DA, Gordon S: Expression and function of the type 3 complement receptor in tissues of the developing mouse. J Immunol 1998, 160:4543-4552
25. Martinez-Pomares L, Reid DM, Brown GD, Taylor PR, Stillion RJ, Linehan SA, Zamze S, Gordon S, Wong SY: Analysis of mannose receptor regulation by IL-4. IL-10, and proteolytic processing using novel monoclonal antibodies. J Leukoc Biol 2003, 73:604-613
26. van der Laan LJ, Kangas M, Dopp EA, Broug-Holub E, Elomaa O, Tryggvason K, Kraal G: Macrophage scavenger receptor MARCO: in vitro and in vivo regulation and involvement in the anti-bacterial host defense. Immunol Lett 1997, 57:203-208
27. Crocker PR, Gordon S: Mouse macrophage hemagglutinin (sheep erythrocyte receptor) with specificity for sialylated glycoconjugates characterized by a monoclonal antibody. J Exp Med 1989, 169:1333-1346
28. Ramprasad MP, Terpstra V, Kondratenko N, Quehenberger O, Steinberg D: Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein. Proc Natl Acad Sci USA 1996, 93:14833-14838
29. Hayward MD, Jones BK, Saparov A, Hain HS, Trillat AC, Bunzel MM, Corona A, Li-Wang B, Strenkowski B, Giordano C, Shen H, Arcamone E, Weidlick J, Vilensky M, Tugusheva M, Felkner RH, Campbell W, Rao Y, Grass DS, Buiakova O: An extensive phenotypic characterization of the hTNFalpha transgenic mice. BMC Physiol 2007, 7:13
30. Petkova-Kirova PS, Gursoy E, Mehdi H, McTiernan CF, London B, Salama G: Electrical remodeling of cardiac myocytes from mice with heart failure due to the overexpression of tumor necrosis factor-alpha. Am J Physiol Heart Circ Physiol 2006, 290:H2098-H2107
31. Saba S, Janczewski AM, Baker LC, Shusterman V, Gursoy EC, Feldman AM, Salama G, McTiernan CF, London B: Atrial contractile dysfunction, fibrosis, and arrhythmias in a mouse model of cardiomyopathy secondary to cardiac-specific overexpression of tumor necrosis factor-{alpha}. Am J Physiol Heart Circ Physiol 2005, 289:H1456-H1467
32. Sivasubramanian N, Coker ML, Kurrelmeyer KM, MacLellan WR, DeMayo FJ, Spinale FG, Mann DL: Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor. Circulation 2001, 104:826-831
33. Engel D, Peshock R, Armstong RC, Sivasubramanian N, Mann DL: Cardiac myocyte apoptosis provokes adverse cardiac remodeling in transgenic mice with targeted TNF overexpression. Am J Physiol Heart Circ Physiol 2004, 287:H1303-H1311
34. Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F, Kollias G: Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 1999, 10:387-398
35. Cope AP, Liblau RS, Yang XD, Congia M, Laudanna C, Schreiber RD, Probert L, Kollias G, McDevitt HO: Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling. J Exp Med 1997, 185:1573-1584
36. Lambin S, van Bree R, Vergote I, Verhaeghe J: Chronic tumor necrosis factor-alpha infusion in gravid C57BL6/J mice accelerates adipose tissue development in female offspring. J Soc Gynecol Investig 2006, 13:558-565
37. Li G, Barrett EJ, Barrett MO, Cao W, Liu Z: Tumor necrosis factoralpha induces insulin resistance in endothelial cells via a p38 mitogen-activated protein kinase-dependent pathway. Endocrinology 2007, 148:3356-3363
38. Iha H, Peloponese JM, Verstrepen L, Zapart G, Ikeda F, Smith CD, Starost MF, Yedavalli V, Heyninck K, Dikic I, Beyaert R, Jeang KT: Inflammatory cardiac valvulitis in TAX1BP1-deficient mice through selective NF-kappaB activation. EMBO J 2008, 27:629-641
39. Amigo MC: The heart and APS. Clin Rev Allergy Immunol 2007, 32:178-183
40. Colao A, Spinelli L, Marzullo P, Pivonello R, Petretta M, Di Somma C, Vitale G, Bonaduce D, Lombardi G: High prevalence of cardiac valve disease in acromegaly: an observational, analytical, case-control study. J Clin Endocrinol Metab 2003, 88:3196-3201
41. Burns JC, Mason WH, Hauger SB, Janai H, Bastian JF, Wohrley JD, Balfour I, Shen CA, Michel ED, Shulman ST, Melish ME: Infliximab treatment for refractory Kawasaki syndrome. J Pediatr 2005, 146: 662-667
42. Edrees AF, Misra SN, Abdou NI: Anti-tumor necrosis factor (TNF) therapy in rheumatoid arthritis: correlation of TNF-alpha serum level with clinical response and benefit from changing dose or frequency of infliximab infusions. Clin Exp Rheumatol 2005, 23:469-474
43. Lamprecht P, Voswinkel J, Lilienthal T, Nolle B, Heller M, Gross WL, Gause A: Effectiveness of TNF-alpha blockade with infliximab in refractory Wegener's granulomatosis. Rheumatology (Oxford) 2002, 41:1303-1307
44. Sfikakis PP, Markomichelakis N, Alpsoy E, Assaad-Khalil S, Bodaghi B, Gul A, Ohno S, Pipitone N, Schirmer M, Stanford M, Wechsler B, Zouboulis C, Kaklamanis P, Yazici H: Anti-TNF therapy in the management of Behcet's disease-review and basis for recommendations. Rheumatology (Oxford) 2007, 46:736-741
45. Guilherme L, Fae KC, Oshiro SE, Tanaka AC, Pomerantzeff PM, Kalil J: Rheumatic fever: how S. pyogenes-primed peripheral T cells trigger heart valve lesions. Ann NY Acad Sci 2005, 1051:132-140
46. Quinn A, Kosanke S, Fischetti VA, Factor SM, Cunningham MW: Induction of autoimmune valvular heart disease by recombinant streptococcal m protein. Infect Immun 2001, 69:4072-4078
47. Pena JM, Garcia-Alegria J, Garcia-Fernandez F, Arnalich F, Barbado FJ, Vazquez JJ: Mitral and aortic regurgitation in Behcet's syndrome. Ann Rheum Dis 1985, 44:637-639
48. Burdick S, Tresch DD, Komokowski RA: Cardiac valvular dysfunction associated with Crohn's disease in the absence of ankylosing spondylitis. Am Heart J 1989, 118:174-176
49. Fukunaga S, Egashira A, Arinaga K, Akasu I, Kai E, Higashi T, Kosuga K, Aoyagi S, Kazue T: Aortic valve replacement for aortic regurgitation due to Kawasaki disease. Report of two cases. J Heart Valve Dis 1996, 5:231-234
50. Oliveira GH, Seward JB, Tsang TS, Specks U: Echocardiographic findings in patients with Wegener granulomatosis. Mayo Clin Proc 2005, 80:1435-1440
51. Misukiewicz P, Carlson RW, Rowan L, Levitt N, Rudnick C, Desai T: Acute aortic insufficiency in a patient with presumed Reiter's syndrome. Ann Rheum Dis 1992, 51:686-687
52. Podell TE, Wallace DJ, Fishbein MC, Bransford K, Klinenberg JR, Levine S: Severe giant cell valvulitis in a patient with Reiter's syndrome. Arthritis Rheum 1982, 25:232-234
53. Iveson JM, Thadani U, Ionescu M, Wright V: Aortic valve incompetence and replacement in rheumatoid arthritis. Ann Rheum Dis 1975, 34:312-320
54. Hayashi I, Hosoda Y, Kawasaki S, Yamamoto T, Dohi S, Kawai S: Aortic and mitral valve replacement in a patient with acute febrile neutrophilic dermatosis (Sweet's syndrome): report of a case. Surg Today 2001, 31:810-813
55. Guilherme L, Cunha-Neto E, Coelho V, Snitcowsky R, Pomerantzeff PM, Assis RV, Pedra F, Neumann J, Goldberg A, Patarroyo ME, Pileggi F, Kalil J: Human heart-infiltrating T-cell clones from rheumatic heart disease patients recognize both streptococcal and cardiac proteins. Circulation 1995, 92:415-420